Login

Financial Snapshot

Revenue
TTM
$40.74M
Gross Margin
TTM
30.59%
Net Income
TTM
-$12.40M
Current Assets
2025 Q3
Current Liabilities
2025 Q3
Current Ratio
2025 Q3
406.89%
Total Assets
2025 Q3
Total Liabilities
2025 Q3
Book Value
2025 Q3
$56.13B
Cash
2025 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$15.24M

Stock Price

Loading...
Market Cap: $2.27 Million

About Universe Pharmaceuticals Inc

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The firm is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.

Industry: Pharmaceutical Preparations Peers: China Pharma Holdings Inc China SXT Pharmaceuticals Inc SUNWIN STEVIA INTERNATIONAL, INC. BGM Group Ltd

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support